Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Dialog provides a comprehensive, modular solution for pharmacovigilance literature monitoring, designed to enhance the efficiency of organizations responsible for drug safety reporting by automating and refining the entire process of literature triage. With access to over 140 reputable scientific and medical literature databases, including MEDLINE, Embase, and Biosis, it standardizes the content from various sources, ensuring a consistent approach to precision search, deduplication, and structured XML output. The DialogML engine utilizes advanced artificial intelligence to prioritize search results based on their relevance to patient safety, identifies critical safety concepts, and categorizes references pertinent to ICSRs (Individual Case Safety Reporting), aggregated reports (PBRER, PSUR, DSUR), and safety signals, enabling reviewers to swiftly pinpoint high-priority articles. Furthermore, the Dialog Alerts Manager enhances the process of creating and managing alerts by providing features such as bulk editing options, comprehensive audit trails for changes in search strategies, flexible scheduling, and detailed tracking of delivery histories. This integrated system significantly reduces the time and effort required for effective literature monitoring, empowering organizations to focus more on critical drug safety issues.
Description
Streamlined surveillance of diverse data sources, seamlessly integrated with a GVP IX compliant signal management platform, can revolutionize your safety data handling. The Evidex platform offers a ready-to-go, GVP-IX compliant signal management solution that simplifies your operations without the hassle of switching between various services. By modernizing your management processes, you can ensure they are audit-proof and efficient. This automation not only helps meet regulatory standards but also enhances the overall value generated for your organization. With automated signal detection, you can identify safety signals from established sources such as ICSR databases, the FDA's Adverse Event Reporting System (FAERS), VigiBase, and clinical trial data. Furthermore, you can incorporate additional data sources, including claims, electronic health records (EHR), and other unstructured information. By aggregating these diverse data pools, you can significantly improve signaling algorithms, streamline validations and assessments, and accelerate responses to pressing drug safety inquiries. Ultimately, this approach transforms how organizations manage and leverage safety data for better outcomes.
API Access
Has API
No
API Access
Has API
No
Integrations
Amazon EC2
No
Amazon RDS
No
Amazon Web Services (AWS)
No
PostgreSQL
No
XML
Yes
Integrations
Amazon EC2
Yes
Amazon RDS
Yes
Amazon Web Services (AWS)
Yes
PostgreSQL
Yes
XML
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
Yes
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Clarivate
Country
United Kingdom
Website
clarivate.com/life-sciences-healthcare/research-development/pharmacovigilance-drug-safety/dialog/
Vendor Details
Company Name
Advera Health Analytics
Founded
2010
Country
United States
Website
www.adverahealth.com